标题
Gene Therapy Tools for Brain Diseases
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-07-01
DOI
10.3389/fphar.2019.00724
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges
- (2018) Hafiz Ishfaq Ahmad et al. CURRENT ISSUES IN MOLECULAR BIOLOGY
- Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model
- (2018) Kasun Kodippili et al. HUMAN GENE THERAPY
- Gene Therapy Using a miniCEP290 Fragment Delays Photoreceptor Degeneration in a Mouse Model of Leber Congenital Amaurosis
- (2018) Wei Zhang et al. HUMAN GENE THERAPY
- Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease
- (2018) Edith L. Pfister et al. HUMAN GENE THERAPY
- Cellular Anti-Silencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate-Early Gene Expression
- (2018) Fang Han et al. JOURNAL OF VIROLOGY
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- Triple Vectors Expand AAV Transfer Capacity in the Retina
- (2018) Andrea Maddalena et al. MOLECULAR THERAPY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polysialic acid is a cellular receptor for human adenovirus 52
- (2018) Annasara Lenman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacology of Recombinant Adeno-associated Virus Production
- (2018) Magalie Penaud-Budloo et al. Molecular Therapy-Methods & Clinical Development
- Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
- (2018) Stéphane Palfi et al. Human Gene Therapy Clinical Development
- Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques
- (2018) Florie Borel et al. Science Translational Medicine
- Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
- (2017) Ken Y Chan et al. NATURE NEUROSCIENCE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection
- (2017) Sean L. Hammond et al. PLoS One
- Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
- (2017) Sarah L. DeVos et al. Science Translational Medicine
- Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer's disease
- (2017) Willem de Haan et al. PLoS Computational Biology
- Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin
- (2017) Edith L. Pfister et al. Molecular Therapy-Nucleic Acids
- Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes
- (2017) Yoshitaka Miyagawa et al. Molecular Therapy-Methods & Clinical Development
- Engineered HSV vector achieves safe long-term transgene expression in the central nervous system
- (2017) Gianluca Verlengia et al. Scientific Reports
- Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivo
- (2016) Yingying Mao et al. BMC BIOTECHNOLOGY
- A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases
- (2016) Jakob Körbelin et al. EMBO Molecular Medicine
- Current status of non-viral gene therapy for CNS disorders
- (2016) Rahul Dev Jayant et al. Expert Opinion on Drug Delivery
- Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector
- (2016) Sourav R Choudhury et al. MOLECULAR THERAPY
- A thalamic input to the nucleus accumbens mediates opiate dependence
- (2016) Yingjie Zhu et al. NATURE
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
- (2016) Benjamin E Deverman et al. NATURE BIOTECHNOLOGY
- PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
- (2016) Loukia Katsouri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease
- (2016) Hyung Ho Yoon et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Genome-Editing Technologies: Principles and Applications
- (2016) Thomas Gaj et al. Cold Spring Harbor Perspectives in Biology
- Systemic delivery of adeno-associated viral vectors
- (2016) Dongsheng Duan Current Opinion in Virology
- Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes
- (2016) Georg von Jonquieres et al. Frontiers in Molecular Neuroscience
- Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
- (2016) Jana Miniarikova et al. Molecular Therapy-Nucleic Acids
- Microglia-specific targeting by novel capsid-modified AAV6 vectors
- (2016) Awilda M Rosario et al. Molecular Therapy-Methods & Clinical Development
- Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors
- (2016) Chiara Falcicchia et al. PLoS One
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Patterned, But Not Tonic, Optogenetic Stimulation in Motor Thalamus Improves Reaching in Acute Drug-Induced Parkinsonian Rats
- (2015) S. Seeger-Armbruster et al. JOURNAL OF NEUROSCIENCE
- Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson’s disease
- (2015) Ilse S. Pienaar et al. Molecular Neurodegeneration
- Optogenetics: 10 years of microbial opsins in neuroscience
- (2015) Karl Deisseroth NATURE NEUROSCIENCE
- Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons
- (2015) Daniel J Urban et al. NEUROPSYCHOPHARMACOLOGY
- Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity
- (2015) Yoshitaka Miyagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OptogenSIM: a 3D Monte Carlo simulation platform for light delivery design in optogenetics
- (2015) Yuming Liu et al. Biomedical Optics Express
- Progresses towards safe and efficient gene therapy vectors
- (2015) Sergiu Chira et al. Oncotarget
- Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors
- (2015) Anne Teissier et al. Cell Reports
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- Chemogenetic Tools to Interrogate Brain Functions
- (2014) Scott M. Sternson et al. Annual Review of Neuroscience
- Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism
- (2014) Sha-Sha Chen et al. EXPERIMENTAL NEUROLOGY
- The potential of adeno-associated viral vectors for gene delivery to muscle tissue
- (2014) Dan Wang et al. Expert Opinion on Drug Delivery
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Global CNS Transduction of Adult Mice by Intravenously Delivered rAAVrh.8 and rAAVrh.10 and Nonhuman Primates by rAAVrh.10
- (2014) Bin Yang et al. MOLECULAR THERAPY
- Chemogenetic Inactivation of Ventral Hippocampal Glutamatergic Neurons Disrupts Consolidation of Contextual Fear Memory
- (2014) Hu Zhu et al. NEUROPSYCHOPHARMACOLOGY
- Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection
- (2014) Jesse R. McLean et al. NEUROSCIENCE LETTERS
- Optogenetic Inactivation of the Subthalamic Nucleus Improves Forelimb Akinesia in a Rat Model of Parkinson Disease
- (2014) Hyung Ho Yoon et al. NEUROSURGERY
- Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates
- (2014) Caroline Le Guiner et al. PLoS One
- Chemical–genetic attenuation of focal neocortical seizures
- (2014) Dennis Kätzel et al. Nature Communications
- Systemic gene delivery to the central nervous system using Adeno-associated virus
- (2014) Mathieu Bourdenx et al. Frontiers in Molecular Neuroscience
- Effective delivery of large genes to the retina by dual AAV vectors
- (2013) Ivana Trapani et al. EMBO Molecular Medicine
- Gene therapy for epilepsy
- (2013) Michele Simonato EPILEPSY & BEHAVIOR
- Non-Coding RNAs: Multi-Tasking Molecules in the Cell
- (2013) Anita Gomes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS
- (2013) Kevin D Foust et al. MOLECULAR THERAPY
- Progress in gene therapy for neurological disorders
- (2013) Michele Simonato et al. Nature Reviews Neurology
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
- (2013) Georg von Jonquieres et al. PLoS One
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
- (2013) Dominik F. Aschauer et al. PLoS One
- On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy
- (2013) Esther Krook-Magnuson et al. Nature Communications
- Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003
- (2013) Subhasish Dutta et al. 3 Biotech
- Lentiviral vectors: basic to translational
- (2012) Toshie Sakuma et al. BIOCHEMICAL JOURNAL
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
- (2012) Arvin C. Dar et al. NATURE
- Generation of Cell Lines to Complement Adenovirus Vectors using Recombination-Mediated Cassette Exchange
- (2011) Susan J Morris et al. BMC BIOTECHNOLOGY
- Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting
- (2011) Reeti Khare et al. CURRENT GENE THERAPY
- The Use of Chromatin Insulators to Improve the Expression and Safety of Integrating Gene Transfer Vectors
- (2011) David W. Emery HUMAN GENE THERAPY
- TerminalN-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
- (2011) Shen Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice
- (2011) Christie L. Bell et al. JOURNAL OF CLINICAL INVESTIGATION
- Several rAAV Vectors Efficiently Cross the Blood–brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System
- (2011) Hongwei Zhang et al. MOLECULAR THERAPY
- Optogenetics in Neural Systems
- (2011) Ofer Yizhar et al. NEURON
- Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System
- (2011) Francisco C. Pérez-Martínez et al. PHARMACEUTICAL RESEARCH
- Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System
- (2011) Piotr Hadaczek et al. PLoS One
- Chemical and Genetic Engineering of Selective Ion Channel-Ligand Interactions
- (2011) C. J. Magnus et al. SCIENCE
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
- (2010) Michael R. Lieber Annual Review of Biochemistry
- Epigenetic regulation of latent HSV-1 gene expression
- (2010) David C. Bloom et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
- (2010) R. Nau et al. CLINICAL MICROBIOLOGY REVIEWS
- Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations
- (2010) Mark M. Souweidane et al. Journal of Neurosurgery-Pediatrics
- A Ubiquitous Chromatin Opening Element (UCOE) Confers Resistance to DNA Methylation–mediated Silencing of Lentiviral Vectors
- (2010) Fang Zhang et al. MOLECULAR THERAPY
- High-performance genetically targetable optical neural silencing by light-driven proton pumps
- (2010) Brian Y. Chow et al. NATURE
- Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
- (2010) Alexxai V. Kravitz et al. NATURE
- Optogenetics
- (2010) Karl Deisseroth NATURE METHODS
- Ultrafast optogenetic control
- (2010) Lisa A Gunaydin et al. NATURE NEUROSCIENCE
- Insulators and promoters: closer than we think
- (2010) Jesse R. Raab et al. NATURE REVIEWS GENETICS
- Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter
- (2010) Jane Yuxia Qin et al. PLoS One
- “Armed” oncolytic herpes simplex viruses for brain tumor therapy
- (2010) Tomoki Todo Cell Adhesion & Migration
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- CTCF: Master Weaver of the Genome
- (2009) Jennifer E. Phillips et al. CELL
- Progress and prospects: Biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors
- (2009) A L Epstein GENE THERAPY
- An Improved Tet-On System for Gene Expression in Neurons Delivered by a Single Lentiviral Vector
- (2009) Xuebi Tian et al. HUMAN GENE THERAPY
- Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - Part 2
- (2009) Radwa A.B. Badawy et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Intranuclear fluorescence resonance energy transfer analysis of plasmid DNA decondensation from nonviral gene carriers
- (2009) Yu Matsumoto et al. JOURNAL OF GENE MEDICINE
- HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties - a review
- (2009) Alberto Luis Epstein MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy
- (2009) Yong Hong Chen et al. NATURE MEDICINE
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors
- (2009) Georgia M. Alexander et al. NEURON
- Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
- (2009) B. Jarraya et al. Science Translational Medicine
- Gene therapy: the end of the rainbow?
- (2009) Edward J Shillitoe Head and Neck Optical Diagnostics Society
- Viral vectors: from virology to transgene expression
- (2008) D Bouard et al. BRITISH JOURNAL OF PHARMACOLOGY
- Homologous recombination in DNA repair and DNA damage tolerance
- (2008) Xuan Li et al. CELL RESEARCH
- GFAPpromoter elements required for region-specific and astrocyte-specific expression
- (2008) Youngjin Lee et al. GLIA
- Lentiviral Vectors Mediate Nonimmunosuppressive Rapamycin Analog-Induced Production of Secreted Therapeutic Factors in the Brain: Regulation at the Level of Transcription and Exocytosis
- (2008) Roland Vogel et al. HUMAN GENE THERAPY
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNA
- (2008) Stefan Worgall et al. HUMAN GENE THERAPY
- Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: Structure effects and in vitro gene transfer properties
- (2008) M. Piest et al. JOURNAL OF CONTROLLED RELEASE
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses
- (2008) D. Grimm et al. JOURNAL OF VIROLOGY
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- FKBP Family Proteins: Immunophilins with Versatile Biological Functions
- (2008) Cong Bao Kang et al. NEUROSIGNALS
- The Argonaute protein family
- (2008) Julia Höck et al. GENOME BIOLOGY
- Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors
- (2007) Ina Gruh et al. JOURNAL OF GENE MEDICINE
- A Hybrid Vector System Expands Adeno-associated Viral Vector Packaging Capacity in a Transgene-independent Manner
- (2007) Arkasubhra Ghosh et al. MOLECULAR THERAPY
- Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic
- (2007) Jon A Wolff et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started